Biogen Newsroom

Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz

Kevin TraversJan 3 16:19 ET

Friday? More Like Grinch Day | Wall Street Today

Kevin TraversJan 3 16:02 ET

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

BenzingaJan 3 13:08 ET

Santa Claus Came Without Rallying the Troops | Live Stock

Kevin TraversJan 3 10:45 ET

Express News | Biogen : Guggenheim Cuts Target Price to $190 From $245

ReutersJan 3 06:25 ET

17 Analysts Assess Biogen: What You Need To Know

BenzingaJan 2 13:00 ET

Piper Sandler Downgrades Biogen to Neutral, Lowers Price Target to $138

BenzingaJan 2 11:17 ET · Ratings

Biogen Analyst Ratings

BenzingaJan 2 11:15 ET · Ratings

Piper Sandler Downgrades Biogen, Slashes PT by $177 Amid Transition Challenges

Yahoo FinanceJan 2 09:25 ET

These Battered S&P 500 Stocks Could Be Ripe for a Turnaround in 2025

Investing.com Jan 2 05:33 ET

Express News | Biogen : Piper Sandler Cuts to Neutral From Overweight

ReutersJan 1 23:51 ET

Why Biogen Inc. (BIIB) Is a Top Value Stock for the Long-Term

Yahoo FinanceJan 1 09:40 ET

These Are the Best and Worst Stocks This Year

BarronsDec 31, 2024 08:56 ET

Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock

Kevin TraversDec 30, 2024 11:01 ET

Biogen Inc. (BIIB): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

Yahoo FinanceDec 28, 2024 16:49 ET

Weekly Buzz: So far, Santa is Letting us Down

Kevin TraversDec 27, 2024 16:59 ET

Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock

Kevin TraversDec 27, 2024 10:52 ET

Investors Aren't Entirely Convinced By Biogen Inc.'s (NASDAQ:BIIB) Earnings

Simply Wall StDec 23, 2024 10:16 ET

2024's Top and Bottom Nasdaq-100 Performers Includes NVDA, APP, INTC, MRNA, and More

Seeking AlphaDec 23, 2024 09:52 ET

Biogen Faces Multiple Analyst Downgrades in December 2024

Yahoo FinanceDec 23, 2024 05:07 ET